The global market for Medicine for Osteoarthritis Pain was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medicine for Osteoarthritis Pain, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medicine for Osteoarthritis Pain by region & country, by Type, and by Application.

The Medicine for Osteoarthritis Pain market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicine for Osteoarthritis Pain.

Market Segmentation

Scope of Medicine for Osteoarthritis Pain - Market Report

Report Metric	Details
Report Name	Medicine for Osteoarthritis Pain - Market
CAGR	5%
Segment by Type:	Oral Injection External
Segment by Application	Medical Care Personal Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medicine for Osteoarthritis Pain manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medicine for Osteoarthritis Pain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medicine for Osteoarthritis Pain in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Medicine for Osteoarthritis Pain - Market report?

Ans: The main players in the Medicine for Osteoarthritis Pain - Market are Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma

What are the Application segmentation covered in the Medicine for Osteoarthritis Pain - Market report?

Ans: The Applications covered in the Medicine for Osteoarthritis Pain - Market report are Medical Care, Personal Care

What are the Type segmentation covered in the Medicine for Osteoarthritis Pain - Market report?

Ans: The Types covered in the Medicine for Osteoarthritis Pain - Market report are Oral, Injection, External

1 Market Overview

1.1 Medicine for Osteoarthritis Pain Product Introduction

1.2 Global Medicine for Osteoarthritis Pain Market Size Forecast

1.2.1 Global Medicine for Osteoarthritis Pain Sales Value (2019-2030)

1.2.2 Global Medicine for Osteoarthritis Pain Sales Volume (2019-2030)

1.2.3 Global Medicine for Osteoarthritis Pain Sales Price (2019-2030)

1.3 Medicine for Osteoarthritis Pain Market Trends & Drivers

1.3.1 Medicine for Osteoarthritis Pain Industry Trends

1.3.2 Medicine for Osteoarthritis Pain Market Drivers & Opportunity

1.3.3 Medicine for Osteoarthritis Pain Market Challenges

1.3.4 Medicine for Osteoarthritis Pain Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Medicine for Osteoarthritis Pain Players Revenue Ranking (2023)

2.2 Global Medicine for Osteoarthritis Pain Revenue by Company (2019-2024)

2.3 Global Medicine for Osteoarthritis Pain Players Sales Volume Ranking (2023)

2.4 Global Medicine for Osteoarthritis Pain Sales Volume by Company Players (2019-2024)

2.5 Global Medicine for Osteoarthritis Pain Average Price by Company (2019-2024)

2.6 Key Manufacturers Medicine for Osteoarthritis Pain Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Medicine for Osteoarthritis Pain Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Medicine for Osteoarthritis Pain

2.9 Medicine for Osteoarthritis Pain Market Competitive Analysis

2.9.1 Medicine for Osteoarthritis Pain Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Medicine for Osteoarthritis Pain Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine for Osteoarthritis Pain as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral

3.1.2 Injection

3.1.3 External

3.2 Global Medicine for Osteoarthritis Pain Sales Value by Type

3.2.1 Global Medicine for Osteoarthritis Pain Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Medicine for Osteoarthritis Pain Sales Value, by Type (2019-2030)

3.2.3 Global Medicine for Osteoarthritis Pain Sales Value, by Type (%) (2019-2030)

3.3 Global Medicine for Osteoarthritis Pain Sales Volume by Type

3.3.1 Global Medicine for Osteoarthritis Pain Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Medicine for Osteoarthritis Pain Sales Volume, by Type (2019-2030)

3.3.3 Global Medicine for Osteoarthritis Pain Sales Volume, by Type (%) (2019-2030)

3.4 Global Medicine for Osteoarthritis Pain Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medical Care

4.1.2 Personal Care

4.2 Global Medicine for Osteoarthritis Pain Sales Value by Application

4.2.1 Global Medicine for Osteoarthritis Pain Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Medicine for Osteoarthritis Pain Sales Value, by Application (2019-2030)

4.2.3 Global Medicine for Osteoarthritis Pain Sales Value, by Application (%) (2019-2030)

4.3 Global Medicine for Osteoarthritis Pain Sales Volume by Application

4.3.1 Global Medicine for Osteoarthritis Pain Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Medicine for Osteoarthritis Pain Sales Volume, by Application (2019-2030)

4.3.3 Global Medicine for Osteoarthritis Pain Sales Volume, by Application (%) (2019-2030)

4.4 Global Medicine for Osteoarthritis Pain Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Medicine for Osteoarthritis Pain Sales Value by Region

5.1.1 Global Medicine for Osteoarthritis Pain Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Medicine for Osteoarthritis Pain Sales Value by Region (2019-2024)

5.1.3 Global Medicine for Osteoarthritis Pain Sales Value by Region (2025-2030)

5.1.4 Global Medicine for Osteoarthritis Pain Sales Value by Region (%), (2019-2030)

5.2 Global Medicine for Osteoarthritis Pain Sales Volume by Region

5.2.1 Global Medicine for Osteoarthritis Pain Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Medicine for Osteoarthritis Pain Sales Volume by Region (2019-2024)

5.2.3 Global Medicine for Osteoarthritis Pain Sales Volume by Region (2025-2030)

5.2.4 Global Medicine for Osteoarthritis Pain Sales Volume by Region (%), (2019-2030)

5.3 Global Medicine for Osteoarthritis Pain Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Medicine for Osteoarthritis Pain Sales Value, 2019-2030

5.4.2 North America Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Medicine for Osteoarthritis Pain Sales Value, 2019-2030

5.5.2 Europe Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Medicine for Osteoarthritis Pain Sales Value, 2019-2030

5.6.2 Asia Pacific Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Medicine for Osteoarthritis Pain Sales Value, 2019-2030

5.7.2 South America Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Medicine for Osteoarthritis Pain Sales Value, 2019-2030

5.8.2 Middle East & Africa Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value

6.2.1 Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.2.2 Key Countries/Regions Medicine for Osteoarthritis Pain Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.3.2 United States Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.4.2 Europe Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.5.2 China Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.5.3 China Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.6.2 Japan Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.7.2 South Korea Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.8.2 Southeast Asia Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Medicine for Osteoarthritis Pain Sales Value, 2019-2030

6.9.2 India Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

6.9.3 India Medicine for Osteoarthritis Pain Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Company Information

7.1.2 Pfizer Introduction and Business Overview

7.1.3 Pfizer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Pfizer Medicine for Osteoarthritis Pain Product Offerings

7.1.5 Pfizer Recent Development

7.2 Johnson and Johnson

7.2.1 Johnson and Johnson Company Information

7.2.2 Johnson and Johnson Introduction and Business Overview

7.2.3 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Johnson and Johnson Medicine for Osteoarthritis Pain Product Offerings

7.2.5 Johnson and Johnson Recent Development

7.3 GlaxoSmithKline

7.3.1 GlaxoSmithKline Company Information

7.3.2 GlaxoSmithKline Introduction and Business Overview

7.3.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Product Offerings

7.3.5 GlaxoSmithKline Recent Development

7.4 Bayer

7.4.1 Bayer Company Information

7.4.2 Bayer Introduction and Business Overview

7.4.3 Bayer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Bayer Medicine for Osteoarthritis Pain Product Offerings

7.4.5 Bayer Recent Development

7.5 Eli Lilly

7.5.1 Eli Lilly Company Information

7.5.2 Eli Lilly Introduction and Business Overview

7.5.3 Eli Lilly Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Eli Lilly Medicine for Osteoarthritis Pain Product Offerings

7.5.5 Eli Lilly Recent Development

7.6 Novartis

7.6.1 Novartis Company Information

7.6.2 Novartis Introduction and Business Overview

7.6.3 Novartis Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Novartis Medicine for Osteoarthritis Pain Product Offerings

7.6.5 Novartis Recent Development

7.7 Sanofi

7.7.1 Sanofi Company Information

7.7.2 Sanofi Introduction and Business Overview

7.7.3 Sanofi Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Sanofi Medicine for Osteoarthritis Pain Product Offerings

7.7.5 Sanofi Recent Development

7.8 Horizon Pharma

7.8.1 Horizon Pharma Company Information

7.8.2 Horizon Pharma Introduction and Business Overview

7.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Horizon Pharma Medicine for Osteoarthritis Pain Product Offerings

7.8.5 Horizon Pharma Recent Development

7.9 Abbott

7.9.1 Abbott Company Information

7.9.2 Abbott Introduction and Business Overview

7.9.3 Abbott Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Abbott Medicine for Osteoarthritis Pain Product Offerings

7.9.5 Abbott Recent Development

7.10 Mylan

7.10.1 Mylan Company Information

7.10.2 Mylan Introduction and Business Overview

7.10.3 Mylan Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Mylan Medicine for Osteoarthritis Pain Product Offerings

7.10.5 Mylan Recent Development

7.11 Daiichi Sankyo

7.11.1 Daiichi Sankyo Company Information

7.11.2 Daiichi Sankyo Introduction and Business Overview

7.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Product Offerings

7.11.5 Daiichi Sankyo Recent Development

7.12 TEVA

7.12.1 TEVA Company Information

7.12.2 TEVA Introduction and Business Overview

7.12.3 TEVA Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.12.4 TEVA Medicine for Osteoarthritis Pain Product Offerings

7.12.5 TEVA Recent Development

7.13 Almatica Pharma

7.13.1 Almatica Pharma Company Information

7.13.2 Almatica Pharma Introduction and Business Overview

7.13.3 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Almatica Pharma Medicine for Osteoarthritis Pain Product Offerings

7.13.5 Almatica Pharma Recent Development

7.14 Astellas Pharma

7.14.1 Astellas Pharma Company Information

7.14.2 Astellas Pharma Introduction and Business Overview

7.14.3 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Astellas Pharma Medicine for Osteoarthritis Pain Product Offerings

7.14.5 Astellas Pharma Recent Development

7.15 Tide Pharmaceutical

7.15.1 Tide Pharmaceutical Company Information

7.15.2 Tide Pharmaceutical Introduction and Business Overview

7.15.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Offerings

7.15.5 Tide Pharmaceutical Recent Development

7.16 Iroko Pharmaceuticals

7.16.1 Iroko Pharmaceuticals Company Information

7.16.2 Iroko Pharmaceuticals Introduction and Business Overview

7.16.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Offerings

7.16.5 Iroko Pharmaceuticals Recent Development

7.17 Hengrui Pharmaceutical

7.17.1 Hengrui Pharmaceutical Company Information

7.17.2 Hengrui Pharmaceutical Introduction and Business Overview

7.17.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.17.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Offerings

7.17.5 Hengrui Pharmaceutical Recent Development

7.18 Abiogen Pharma

7.18.1 Abiogen Pharma Company Information

7.18.2 Abiogen Pharma Introduction and Business Overview

7.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

7.18.4 Abiogen Pharma Medicine for Osteoarthritis Pain Product Offerings

7.18.5 Abiogen Pharma Recent Development

8 Industry Chain Analysis

8.1 Medicine for Osteoarthritis Pain Industrial Chain

8.2 Medicine for Osteoarthritis Pain Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Medicine for Osteoarthritis Pain Sales Model

8.5.2 Sales Channel

8.5.3 Medicine for Osteoarthritis Pain Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

List of Tables

Table 1. Medicine for Osteoarthritis Pain Market Trends

Table 2. Medicine for Osteoarthritis Pain Market Drivers & Opportunity

Table 3. Medicine for Osteoarthritis Pain Market Challenges

Table 4. Medicine for Osteoarthritis Pain Market Restraints

Table 5. Global Medicine for Osteoarthritis Pain Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Medicine for Osteoarthritis Pain Revenue Market Share by Company (2019-2024)

Table 7. Global Medicine for Osteoarthritis Pain Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Medicine for Osteoarthritis Pain Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Medicine for Osteoarthritis Pain Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Medicine for Osteoarthritis Pain Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Medicine for Osteoarthritis Pain Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Medicine for Osteoarthritis Pain

Table 13. Global Medicine for Osteoarthritis Pain Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine for Osteoarthritis Pain as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Medicine for Osteoarthritis Pain Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Medicine for Osteoarthritis Pain Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Medicine for Osteoarthritis Pain Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Medicine for Osteoarthritis Pain Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Medicine for Osteoarthritis Pain Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Medicine for Osteoarthritis Pain Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Medicine for Osteoarthritis Pain Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Medicine for Osteoarthritis Pain Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Medicine for Osteoarthritis Pain Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Medicine for Osteoarthritis Pain Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Medicine for Osteoarthritis Pain Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Medicine for Osteoarthritis Pain Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Medicine for Osteoarthritis Pain Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Medicine for Osteoarthritis Pain Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Medicine for Osteoarthritis Pain Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Medicine for Osteoarthritis Pain Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Medicine for Osteoarthritis Pain Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Medicine for Osteoarthritis Pain Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Medicine for Osteoarthritis Pain Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Medicine for Osteoarthritis Pain Sales Value by Region (2019-2024) & (%)

Table 44. Global Medicine for Osteoarthritis Pain Sales Value by Region (2025-2030) & (%)

Table 45. Global Medicine for Osteoarthritis Pain Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Medicine for Osteoarthritis Pain Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Medicine for Osteoarthritis Pain Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Medicine for Osteoarthritis Pain Sales Volume by Region (2019-2024) & (%)

Table 49. Global Medicine for Osteoarthritis Pain Sales Volume by Region (2025-2030) & (%)

Table 50. Global Medicine for Osteoarthritis Pain Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Medicine for Osteoarthritis Pain Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Volume, (2025-2030) & (K Units)

Table 57. Pfizer Company Information

Table 58. Pfizer Introduction and Business Overview

Table 59. Pfizer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Pfizer Medicine for Osteoarthritis Pain Product Offerings

Table 61. Pfizer Recent Development

Table 62. Johnson and Johnson Company Information

Table 63. Johnson and Johnson Introduction and Business Overview

Table 64. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Johnson and Johnson Medicine for Osteoarthritis Pain Product Offerings

Table 66. Johnson and Johnson Recent Development

Table 67. GlaxoSmithKline Company Information

Table 68. GlaxoSmithKline Introduction and Business Overview

Table 69. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. GlaxoSmithKline Medicine for Osteoarthritis Pain Product Offerings

Table 71. GlaxoSmithKline Recent Development

Table 72. Bayer Company Information

Table 73. Bayer Introduction and Business Overview

Table 74. Bayer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Bayer Medicine for Osteoarthritis Pain Product Offerings

Table 76. Bayer Recent Development

Table 77. Eli Lilly Company Information

Table 78. Eli Lilly Introduction and Business Overview

Table 79. Eli Lilly Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Eli Lilly Medicine for Osteoarthritis Pain Product Offerings

Table 81. Eli Lilly Recent Development

Table 82. Novartis Company Information

Table 83. Novartis Introduction and Business Overview

Table 84. Novartis Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Novartis Medicine for Osteoarthritis Pain Product Offerings

Table 86. Novartis Recent Development

Table 87. Sanofi Company Information

Table 88. Sanofi Introduction and Business Overview

Table 89. Sanofi Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Sanofi Medicine for Osteoarthritis Pain Product Offerings

Table 91. Sanofi Recent Development

Table 92. Horizon Pharma Company Information

Table 93. Horizon Pharma Introduction and Business Overview

Table 94. Horizon Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Horizon Pharma Medicine for Osteoarthritis Pain Product Offerings

Table 96. Horizon Pharma Recent Development

Table 97. Abbott Company Information

Table 98. Abbott Introduction and Business Overview

Table 99. Abbott Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Abbott Medicine for Osteoarthritis Pain Product Offerings

Table 101. Abbott Recent Development

Table 102. Mylan Company Information

Table 103. Mylan Introduction and Business Overview

Table 104. Mylan Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Mylan Medicine for Osteoarthritis Pain Product Offerings

Table 106. Mylan Recent Development

Table 107. Daiichi Sankyo Company Information

Table 108. Daiichi Sankyo Introduction and Business Overview

Table 109. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Daiichi Sankyo Medicine for Osteoarthritis Pain Product Offerings

Table 111. Daiichi Sankyo Recent Development

Table 112. TEVA Company Information

Table 113. TEVA Introduction and Business Overview

Table 114. TEVA Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. TEVA Medicine for Osteoarthritis Pain Product Offerings

Table 116. TEVA Recent Development

Table 117. Almatica Pharma Company Information

Table 118. Almatica Pharma Introduction and Business Overview

Table 119. Almatica Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Almatica Pharma Medicine for Osteoarthritis Pain Product Offerings

Table 121. Almatica Pharma Recent Development

Table 122. Astellas Pharma Company Information

Table 123. Astellas Pharma Introduction and Business Overview

Table 124. Astellas Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Astellas Pharma Medicine for Osteoarthritis Pain Product Offerings

Table 126. Astellas Pharma Recent Development

Table 127. Tide Pharmaceutical Company Information

Table 128. Tide Pharmaceutical Introduction and Business Overview

Table 129. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Offerings

Table 131. Tide Pharmaceutical Recent Development

Table 132. Iroko Pharmaceuticals Company Information

Table 133. Iroko Pharmaceuticals Introduction and Business Overview

Table 134. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Offerings

Table 136. Iroko Pharmaceuticals Recent Development

Table 137. Hengrui Pharmaceutical Company Information

Table 138. Hengrui Pharmaceutical Introduction and Business Overview

Table 139. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 140. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Offerings

Table 141. Hengrui Pharmaceutical Recent Development

Table 142. Abiogen Pharma Company Information

Table 143. Abiogen Pharma Introduction and Business Overview

Table 144. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 145. Abiogen Pharma Medicine for Osteoarthritis Pain Product Offerings

Table 146. Abiogen Pharma Recent Development

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Medicine for Osteoarthritis Pain Downstream Customers

Table 150. Medicine for Osteoarthritis Pain Distributors List

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Medicine for Osteoarthritis Pain Product Picture

Figure 2. Global Medicine for Osteoarthritis Pain Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Medicine for Osteoarthritis Pain Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Medicine for Osteoarthritis Pain Sales Volume (2019-2030) & (K Units)

Figure 5. Global Medicine for Osteoarthritis Pain Sales Price (2019-2030) & (USD/Unit)

Figure 6. Medicine for Osteoarthritis Pain Report Years Considered

Figure 7. Global Medicine for Osteoarthritis Pain Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Medicine for Osteoarthritis Pain Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Medicine for Osteoarthritis Pain Revenue in 2023

Figure 10. Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oral Picture

Figure 12. Injection Picture

Figure 13. External Picture

Figure 14. Global Medicine for Osteoarthritis Pain Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Medicine for Osteoarthritis Pain Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Medicine for Osteoarthritis Pain Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Medicine for Osteoarthritis Pain Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Medicine for Osteoarthritis Pain Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of Medical Care

Figure 20. Product Picture of Personal Care

Figure 21. Global Medicine for Osteoarthritis Pain Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Medicine for Osteoarthritis Pain Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Medicine for Osteoarthritis Pain Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Medicine for Osteoarthritis Pain Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Medicine for Osteoarthritis Pain Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Medicine for Osteoarthritis Pain Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Medicine for Osteoarthritis Pain Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Medicine for Osteoarthritis Pain Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Medicine for Osteoarthritis Pain Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Medicine for Osteoarthritis Pain Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Medicine for Osteoarthritis Pain Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Medicine for Osteoarthritis Pain Sales Volume (%), (2019-2030)

Figure 38. United States Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 44. China Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 46. China Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 56. India Medicine for Osteoarthritis Pain Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Medicine for Osteoarthritis Pain Sales Value by Type (%), 2023 VS 2030

Figure 58. India Medicine for Osteoarthritis Pain Sales Value by Application (%), 2023 VS 2030

Figure 59. Medicine for Osteoarthritis Pain Industrial Chain

Figure 60. Medicine for Osteoarthritis Pain Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions